Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death (original) (raw)

• Rosenberg, S.A. et ai. Immunization of cancer patients using autologous cancer Cells modified by insertion of the gene for interleukin-2. Hum. Gene Ther. 3, 75–90 (1992).
  Article Google Scholar
• Culver, K.W. et al. In vivo gene transfer with retroviral vector producer Cells for treatment of experimental brain tumors. Science 256, 1550–1552 (1992).
  Article CAS PubMed Google Scholar
• Zhang, Y. et al. Retroviral vector-mediated transduction of K-ras antisense RNA into human cancer Cells inhibits expression of the malignant phenotype. Hum. Gene Ther. 4, 451–460 (1993).
  Article CAS PubMed Google Scholar
• Friedmann, T. Gene therapy of cancer through restoration of tumor-suppressor functions? Cancer 70 (Suppl.), 1810–1817 (1992).
  Article CAS PubMed Google Scholar
• Mulligan, R.C. The basic science of gene therapy. Science 260, 926–932 (1993).
  Article CAS PubMed Google Scholar
• Kremer, E.J. & Perricaudet, M. Adenovirus and adeno-associated virus mediated gene transfer. British Med. Bull. 51, 31–44 (1995).
  Article CAS Google Scholar
• Kozarsky, K.F. & Wilson, J.M. Gene therapy: Adenovirus vectors. Curr. Opin. Cen. Dev. 3, 499–503 (1993).
  Article CAS Google Scholar
• Kass-Eisler, A. et al. The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Therapy 1, 395–402 (1994).
  CAS PubMed Google Scholar
• Huard, J. et al. The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Therapy 2, 107–115 (1995).
  CAS PubMed Google Scholar
• Herz, J. & Gerard, R.D. Adenovirus-mediated low-density-lipoprotein receptor gene transfer accelerated cholesterol clearance in normal mice. Proc. Natl. Acad. Sd. USA 90, 2812–281 6 (1993).
  Article CAS Google Scholar
• Liu, T.-J. et al. Growth suppression of human head and neck cancer Cells by the introduction of a wild-type pS3 gene via a recombinant adenovirus. Cancer Res. 54, 3662–3667 (1994).
  CAS PubMed Google Scholar
• Zhang, W.-W. et al. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer Cells mediated by recombinant adenovirus. Cancer Gene Ther. 1, 1–10 (1994).
  Google Scholar
• Clayman, G.L. et al. In vivo molecular therapy with p53 adenovirus for micror scopic residual head and neck squamous carcinoma. Cancer Res. 55, 1–6 (1995).
  CAS PubMed Google Scholar
• Weinberg, R.A. The retinoblastoma protein and Cell cycle control. Cell 81, 323–330 (1995).
  Article CAS PubMed Google Scholar
• Strauss, M., Lukas, J. & Bartek, J., Unrestricted Cell cycling and cancer. Nature Med. 1, 1245–1246 (1995).
  Article CAS PubMed Google Scholar
• Sheer, C.J. & Roberts, J.M. Inhibitors of mammalian Gl cyclin-dependent ki-nases. Genes Dev. 9, 1149–1163 (1995).
  Article Google Scholar
• He, A. et al. CDK4 amplification is an alternative mechanism to p16 gene ho-mozygous deletion in glioma Cell lines. Cancer Res. 54, 5804–5807 (1994).
  CAS PubMed Google Scholar
• Motukura, T. & Arnold, A. Cyclins and oncogenesis. Biochem. Biophys. Acta 1155, 63–78 (1993).
  Google Scholar
• Bates, S. & Peters, G. Cyclin D1 as a Cellular protooncogene. Sem. Cancer Biol. 6, 73–82 (1995).
  Article CAS Google Scholar
• Kamb, A. et al. A Cell cycle regulator potentially involved in genesis of many tumor types. Science 264, 436–440 (1994).
  Article CAS PubMed Google Scholar
• Nobori, T. et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancer. Nature 368, 753–756 (1994).
  Article CAS PubMed Google Scholar
• Merlo, A. et al. 5'CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN/MTS1 in human cancers. Nature Med. 1, 686–692 (1995).
  Article CAS PubMed Google Scholar
• Ottersen, G.A., Kratzke, T.A., Coxon, A., Kim, Y.W. & Kaye, F.J. Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wild-type RB. Oncogene 9 3375–378 (1994).
  Google Scholar
• Okamoto, A. et al. Mutations and altered expression of p16INK4 in human cancer. Proc. Natl. Acad. Sd. USA 91, 11045–1049 (1994).
  Article CAS Google Scholar
• Aagaard, L. et al. Aberrations of p16INK4 and retinoblastoma tumor-suppressor genes occur in distinct sub-sets of human cancer Cell lines. Intl. J. Cancer 61, 115–20 (1995).
  Article CAS Google Scholar
• Elledge, S.J. et al. The p21 cdk-interacting protein cip1 is potent inhibitor of Gl cyclin-dependent kinases. Cell 75, 805–816 (1993)
  Article PubMed Google Scholar
• Xiong, Y. et al. p21 is a universal inhibitor of cyclin kinases. Nature 366, 701–704 (1993).
  Article CAS PubMed Google Scholar
• Deng, C., Zhang, P., Harer, W.J., Elledge, S.J., & Leder, P., Mice lacking P21CIPI/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82, 675–684 (1995).
  Article CAS PubMed Google Scholar
• Jin, X., Nguyen, D., Zhang, W.-W., Kyritsis, A.P. & Roth, J.A. Cell cycle arrest and inhibition of tumor Cell proliferation by the p16_INK4_ gene mediated by an adenovirus vector. Cancer Res. 55, 3250–3252 (1995).
  CAS PubMed Google Scholar
• Yang, Z.-Y., Perkins, N.D., Ohno, T., Nabel, E.G. & Nabel, G.J. The p21 cyclindependent kinase inhibitor suppresses tumorigenicity in vivo. Nature Med. 1, 1052–1056 (1995).
  Article CAS PubMed Google Scholar
• Eastham, J.A. et al. In vivo gene therapy with p53 or p21 and adenovirus for prostate cancer. Cancer Res. 55, 5151–5155 (1995).
  CAS PubMed Google Scholar
• Rowan, S. et al. Specific loss of apoptotic but not Cell cycle arrest function in a human tumour derived p53 mutant. EMBO J. 15, 827–838 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• White, E., ife, death, and the pursuit of apoptosis. Genes Dev. 10, 1–15 (1996).
  Article CAS PubMed Google Scholar
• Roth, J.A. et al. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nature Med. 2, 985–991 (1996)
  Article CAS PubMed Google Scholar
• Haas-Kogan, D.A. et al. Inhibition of apoptosis by the retinoblastoma gene product. EMB0 J. 14, 461–72 (1995).
  Article CAS Google Scholar
• Lukas, J. et al. Retinoblastoma-protein-dependent Cell-cycle inhibition by the tumour suppressor p16. Nature 375, 503–506 (1995).
  Article CAS PubMed Google Scholar
• Bates, S. & Vousden, K.H. . p53 in signaling checkpoint arrest or apoptosis. Curr. Opin. Cenet. Dev. 6, 12–19 (1996).
  Article CAS Google Scholar
• Gill, R.M. et al. Characterization of the human RBI promoter and of elements involved in transcriptional regulation. Cell Growth Diff. 5, 467–474 (1994).
  CAS PubMed Google Scholar
• An, B. & Dou, Q.P. Cleavage of retinoblastoma protein during apoptosis: An interleukin 1β-converting enzyme-like protease as candidate. Cancer Res. 56, 438–442 (1996).
  CAS PubMed Google Scholar
• Nevins, J.R. E2F: A link between the Rb tumor suppressor protein and viral onco-proteins. Science 258, 424–428 (1992).
  Article CAS PubMed Google Scholar
• Qin, X.-Q., Livingston, D.M., Kaelin, W.G. & Adams, P.D. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Notl. Acad. Sci. USA 91, 10918–10922 (1994).
  Article CAS Google Scholar
• Shan, B. & Lee, W.H. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell Biol. 14, 8166–8173 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Wu, X. & Levine, A.J. . p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91, 3602–3606 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Oltvai, Z.N., Miliman, C.L. & Korsmeyer, S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed Cell death. Cell 74, 609–619 (1993).
  Article CAS PubMed Google Scholar
• Miyashita, T. & Reed, J.C. Tumor suppressor p53 is a direct transcriptional activator of the human box gene. Cell 80, 293–299 (1995).
  Article CAS PubMed Google Scholar
• Yang, C., Cirielli, C., Capogrossi, M.C. & Passaniti, A. Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of prostatic tumor Cells. Cancer Res. 55, 4210–4213 (1995).
  CAS PubMed Google Scholar
• Bett, A.J., Haddara, W., Prevec, L. & Graham, F.L. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. USA 91, 8802–8806 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• McGrory, W.J., Bautista, D.S. & Graham, F.L. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology 163, 614–617 (1988).
  Article CAS PubMed Google Scholar
• Lieber, A., Sandig, V., Sommer, W., Bähring, S. & Strauss, M. Stable high-level gene expression in mammalian Cells by T7phage RNA polymerase. In Recombinant DNA Methodology II (ed. Wu, R.) 257–276 (Selected Meth. Enzymol., Academic Press, 1995).
  Chapter Google Scholar
• Kanegae, Y., Makimura, M. & Saito, I. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn. J. Med. Sci. Biol. 47, 157–166 (1994).
  Article CAS PubMed Google Scholar
• Carlsson, G., Gullberg, B. & Hafström, L. Estimation of liver tumor volume using different formulas — an experimental study in rats. J. Cancer Res. Clin. Oncol. 105, 20–23 (1983).
  Article CAS PubMed Google Scholar